Purdue Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PURDUE PHARMA, and what generic alternatives to PURDUE PHARMA drugs are available?
PURDUE PHARMA has eleven approved drugs.
There are fifty-five US patents protecting PURDUE PHARMA drugs.
There are seven hundred and sixty-four patent family members on PURDUE PHARMA drugs in fifty-one countries and eight supplementary protection certificates in five countries.
Summary for Purdue Pharma
| International Patents: | 764 |
| US Patents: | 55 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 11 |
| Patent Litigation for Purdue Pharma: | See patent lawsuits for Purdue Pharma |
| PTAB Cases with Purdue Pharma as petitioner: | See PTAB cases with Purdue Pharma as petitioner |
| PTAB Cases with Purdue Pharma as patent owner: | See PTAB cases with Purdue Pharma as patent owner |
Drugs and US Patents for Purdue Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-006 | Feb 27, 2019 | DISCN | Yes | No | 10,512,612 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-003 | Feb 27, 2019 | DISCN | Yes | No | 10,722,473 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | RX | Yes | No | 9,775,808 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Purdue Pharma Lp | ADHANSIA XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212038-002 | Feb 27, 2019 | DISCN | Yes | No | 10,507,186 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-006 | Nov 20, 2014 | AB | RX | Yes | No | 9,492,390 | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Purdue Pharma Lp | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-002 | Nov 20, 2014 | AB | RX | Yes | No | 9,492,389 | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
| Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-004 | Apr 5, 2010 | RX | Yes | No | 10,369,109 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Purdue Pharma
Paragraph IV (Patent) Challenges for PURDUE PHARMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 15 mg | ➤ Subscribe | 2007-02-15 |
| ➤ Subscribe | Sublingual Tablets | 1.75 mg and 3.5 mg | ➤ Subscribe | 2012-04-10 |
| ➤ Subscribe | Transdermal System | 15 mcg/hr | ➤ Subscribe | 2013-12-16 |
| ➤ Subscribe | Extended-release Tablets | 30 mg, 40 mg, 80 mg, and 100 mg | ➤ Subscribe | 2015-05-08 |
| ➤ Subscribe | Extended-release Tablets | 30 mg and 60 mg | ➤ Subscribe | 2007-01-03 |
| ➤ Subscribe | Extended-release Tablets | 100 mg, 200 mg and 300 mg | ➤ Subscribe | 2009-06-18 |
| ➤ Subscribe | Transdermal System | 5 mcg/hr, 10 mcg/hr, and 20 mcg/hr | ➤ Subscribe | 2013-06-06 |
| ➤ Subscribe | Extended-release Tablets | 20 mg, 60 mg, and 120 mg | ➤ Subscribe | 2015-04-15 |
International Patents for Purdue Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 1730151 | ⤷ Try a Trial |
| China | 102688213 | ⤷ Try a Trial |
| Argentina | 046994 | ⤷ Try a Trial |
| Montenegro | 01550 | ⤷ Try a Trial |
| Ukraine | 104745 | ⤷ Try a Trial |
| Mexico | 2021016109 | ⤷ Try a Trial |
| Argentina | 103463 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Purdue Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| 2236132 | 92636 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES |
| 2236132 | 300714 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 108438 - 439 20160624; REGISTRATION NO/DATE: BE424286 20120718 BE424295 20120718 |
| 2236132 | 122015000006 | Germany | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718 |
| 2236132 | C300714 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718 |
| 0566709 | C300152 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
| 1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
